|Articles|November 27, 2021

First of a New Class of Drugs to Treat Early-Stage Triple-Negative Breast Cancer Approved

A promising new drug for treating this type of breast cancers in its early stages may help prevent the return of cancer.

Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with limited treatment options. A promising new drug for treating this type of breast cancers in its early stages may help prevent the return of cancer. Read more in our XRAY review. #helpnothype #BehindtheCancerHeadlines

https://www.facingourrisk.org/XRAY/pembrolizumab-for-triple-negative-breast-cancer?utm_source=CURE&utm_medium=website&utm_campaign=organic_social_website

Stay up to date on cancer updates, research and education

Subscribe Now!

First of a New Class of Drugs to Treat Early-Stage Triple-Negative Breast Cancer Approved

Newsletter

Trending on CURE

FDA Grants Breakthrough Therapy Designation to Ficerafusp Alfa in Head and Neck Cancer

What Subcutaneous Keytruda Means for Patients With Melanoma

What the FDA Approval of Inluriyo Means for Patients With Breast Cancer

Early Detection and Misconceptions in Lung Cancer

Breast Cancer Awareness Month Isn’t Always “Pink and Pretty”